These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Mettler FP; Young DM; Ward JM Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096 [No Abstract] [Full Text] [Related]
6. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK; Newman MS; Sullivan T; Yarrington J J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696 [TBL] [Abstract][Full Text] [Related]
7. Editorial: Adriamycin and the heart. Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302 [No Abstract] [Full Text] [Related]
8. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice. Forrest GL; Gonzalez B; Tseng W; Li X; Mann J Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643 [TBL] [Abstract][Full Text] [Related]
9. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat]. Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790 [No Abstract] [Full Text] [Related]
10. Adriamycin cardiac toxicity: a different hypothesis. Byfield JE Cancer Treat Rep; 1977; 61(3):497-8. PubMed ID: 872149 [No Abstract] [Full Text] [Related]
11. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy. Benjamin RS; Mason JW; Billingham ME Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871 [No Abstract] [Full Text] [Related]
13. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846 [TBL] [Abstract][Full Text] [Related]
14. Adriamycin and the heart. Henderson IC; Frei TE N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884 [No Abstract] [Full Text] [Related]
15. A clinicopathologic analysis of adriamycin cardiotoxicity. Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012 [No Abstract] [Full Text] [Related]
16. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity. Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864 [No Abstract] [Full Text] [Related]
17. [Adriamycin induced chronic cardiotoxicity: a morphological ultrastructural study on ventricular myocardium and conducting system of rabbit heart (author's transl)]. Gandolfi A Ateneo Parmense Acta Biomed; 1976; 47(1):69-78. PubMed ID: 1016274 [TBL] [Abstract][Full Text] [Related]
18. Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds. Greco FA Cancer Treat Rep; 1978 Jun; 62(6):901-5. PubMed ID: 667865 [No Abstract] [Full Text] [Related]
19. Detection of adriamycin cardiotoxicity by echocardiography. Ewy GA; Jones SE; Groves BM; Gaines JA Ariz Med; 1978 Jun; 35(6):402-5. PubMed ID: 687134 [No Abstract] [Full Text] [Related]